The data indicated the significant expression of CUX2 in selected B-cell lines derived from Burkitt lymphoma (RAMOS), diffuse large B-cell lymphoma (SU-DHL-4, WSU-DLCL2) and Hodgkin lymphoma (DEV). This evidence concerns the gene CUX2 and Burkitt lymphoma.